BIO Bio-Rad Laboratories Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
12:09
May 18
Newsquawk Newswire (@Newsquawk)
Elliott Management disclosed building a new stake in BIO per 13F filing.
BIO
HIGH
00:46
May 18
Bloomberg Newswire (@business)
Elliott Management disclosed a long stake in Bio-Rad (BIO) to boost stock price.
BIO
HIGH
00:42
May 18
BarbarianCap Twitter Analyst
Reports that activist investor Elliott Management has built a significant stake in Bio-Rad, a potential catalyst for strategic or operational changes.
BIO
HIGH
00:26
May 18
FirstSquawk Newswire (@FirstSquawk)
Elliott Investment Management disclosed a significant long stake in Bio-Rad Laboratories (BIO).
BIO
HIGH
22:37
May 07
Minnvestor Tech/Semiconductor growth investor
Buy a basket of healthcare/diagnostics stocks as a low‑conviction hedge against a potential hantavirus outbreak; small position sizes, speculative catalyst.
BIO 1ST
HIGH
13:37
May 02
joshuadeuk
Buy BIO as decentralized science gains legitimacy through Eli Lilly acquisition of VitaDAO-backed CrossBridge Bio, an ADHD peptide breakthrough, and BixBench product adoption by Harvard, Stanford, Cambridge, and Pfizer; token needs renewed flow but fundamentals are improving.
BIO 1ST
HIGH

About BIO Analyst Coverage

Buzzberg tracks BIO (Bio-Rad Laboratories) across 6 sources. 2 bullish vs 0 bearish calls from 6 analysts. Sentiment: predominantly bullish (33%). 6 total trade ideas tracked. Latest voices: Newsquawk, Bloomberg, BarbarianCap.